Last reviewed · How we verify
MOB015B vehicle — Competitive Intelligence Brief
phase 3
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
MOB015B vehicle (MOB015B vehicle) — Moberg Pharma AB. MOB015B is a topical vehicle formulation designed to enhance drug delivery and penetration through the skin barrier.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| MOB015B vehicle TARGET | MOB015B vehicle | Moberg Pharma AB | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- MOB015B vehicle CI watch — RSS
- MOB015B vehicle CI watch — Atom
- MOB015B vehicle CI watch — JSON
- MOB015B vehicle alone — RSS
Cite this brief
Drug Landscape (2026). MOB015B vehicle — Competitive Intelligence Brief. https://druglandscape.com/ci/mob015b-vehicle. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab